Hemofiltration treatment for sepsis. Is it time for controlled trials?

Kidney International, Supplement

Volumn 56, Issue 72, 1999, Pages

  Rogiers, Peter ^a  

^a MIDDELHEIM HOSPITAL   (Belgium)

Author keywords

Acute endotoxic shock; Biocompatible membranes; Continuous arteriovenous hemofiltration; Cytokines; Hemodynamics

Indexed keywords

AUTACOID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; CLINICAL TRIAL; DISEASE MODEL; FORECASTING; HEMOFILTRATION; HUMAN; METABOLISM; METHODOLOGY; SEPSIS; SEPTIC SHOCK; STANDARD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTIFICIAL KIDNEY; BIOCOMPATIBILITY; BLOOD FILTER; NONHUMAN; PRIORITY JOURNAL; SWINE; TREATMENT INDICATION; ULTRAFILTRATION;

ANIMALS; CLINICAL TRIALS; DISEASE MODELS, ANIMAL; FORECASTING; HEMOFILTRATION; HUMANS; INFLAMMATION MEDIATORS; SEPSIS; SHOCK, SEPTIC;

EID: 0032702690     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. STEIN B, PFENNINOER E, GRUNERT A, SCHMITZ JE, HUDDE M. Influence of continuous hemofiltration on hemodynamics and central blood in experimental endotoxic shock. Intensive Care Med 16:494499, 1990
2. FREEMAN BD, YATSIV I, NATANSON C, SOLOMON MA, QUEZADO ZM, DANNER RL, BANKS SM, HUFFMAN \VD. Continuous arteriovenous hemofiltration does not improve survival in a canine model of septic shock. J Am Colt Surg 180:286-292, 1995
3. GOMEZ A, WANG R, UNRUH H, LIGHT RB, BöSE D, CHAU T, CORREA E, MINK S. Hemofiltration reverses left ventricular dysfunction during sepsis in dogs. Anesthesiology 73:671-685, 1990
4. MINK SN, JHA P, WANG R, YANG J, BOSE D, JACOBS H, LIGHT RB. Effects of continuous arteriovenous hemofiltration with systemic vasopressor therapy on depressed left ventricular contractility and tissue oxygen delivery in canine Escherichia coli sepsis. Anesthesiology 83:178-190, 1995
5. HEIDEMANN SM, OFENSTEIN JP, SARNAIK AP. Efficacy of continuous arteriovenous hemofiltration in endotoxic shock. Circ Shock 44:183-187, 1994
6. LEE PA, MATSON JR, PRYOR RW, HINSHAW LB. Continuous arteriovenous hemofiltration therapy for Staphylococcus aureus induced septicemia in immature swine. Crit Care Med 21:914-924, 1993
7. GROOTENDORST AF, VAN BOMMEL EFH, VAN DER HOVEN B, VAN LEENGOED LAMG, VAN OSTA G ALM. High-volume hemofiltration improves hemodynamics of endotoxin-induced shock in the pig. / Crit Care 7:67-75, 1992
8. GROOTENDORST AF, VAN BOMMEL EFH, VAN DER HOVEN B, VAN LEENGOED LAMG, VAN OSTA G ALM. High-volume hemofiltration improves right ventricular function of endotoxin induced shock in the pig. Intensive Care Med 18:235-240, 1992
9. GROOTENDORST AF, VAN BOMMEL EF, VAN LEENGOED LA, NABUURS M, BOUMAN CS, GROENEVELD AB. High-volume hemofiltration improves hemodynamics and survival of pigs exposed to gut ischemia and reperfusion. Shock 2:72-78, 1994
10. ROGIERS P, ZHANG H, SMAIL N, PAUWELS D, VINCENT J-L. CVVH improves cardiac performance by mechanisms other than TNF attenuation during endotoxic shock. Crit Care Med (in press)
11. MURPHEY ED, FESSLER JF, BOTTOMS GD, LATSHAW H, JOHNSON M, MUELLER B, CLARK W, MAACIAS W. Effects of continuous venovenous hemofiltration on cardiopulmonary function in a porcine model of endotoxin-induced shock. J Vet Res 58:408-413, 1997
12. LEE PA, WEGER GW, PRYOR RW, MATSON JR. Effects of filter pore size on efficacy of continuous arteriovenous hemofiltration therapy for Staphylococcus aiirera-induced septicemia in immature swine. Crit Care Med 26:730-737,1998
13. KLINE JA, GORDON BE, WILLIAMS C, BLUMENTHAL S, WATTS JA, DiAZ-Buxo J. Large-pore hemodialysis in acute endotoxin shock. Crit Care Med 27:588-596, 1999
14. LONNEMAN G, SCHINDLER R, DiNARELLO CA, KOCH KM. Removal of cytokines by hemodialysis membrane in vitro, in Host Defense Dysfunction in Trauma, Shock and Sepsis, edited by FAIST E, MEAKINS J, SCHILDBERG FW, Berlin, Heidelberg, New York, Springer, 1993, pp 613-623
15. BARRERA P, JANSSEN EM, DEMACKER PN, WETZELS JF, VAN DER MEER JW. Removal of interleukin-1 beta and TNF from human plasma by in vitro dialysis with polyacrylonitrile membranes. Lymphokine Cytokine Res 11:99-104, 1992
16. GOLDFARB S, GOLFER TA. Pro-inflammatory cytokines and hemofiltration membranes. / Am Soc Nephrol 5:228-232, 1994
17. NAGAKI M, HUGHES RD, LAU JY, WILLIAMS R. Removal of endotoxin and cytokines by adsorbents and the effects of plasma protein binding. Int J Artif Organs 14:43-50, 1991
18. JOURNOIS D. Complement fragments and cytokines. Production and removal as consequences of hemofiltration. Conlrib Nephrol 116:80-85, 1995
19. CHEADLE WG, HANASAWA K, GALLINARO RN, NIMMANWUDIPONG T, KODAMA M, POLK HC JR. Endotoxin filtration and immune stimulation improve survival from gram-negative sepsis. Surgery 110:785-792, 1991
20. JABER BL, BARRETTTW, CENDOROGLO NETO M, SUNDARAM S, KING AJ, PEREIRA BJ. Endotoxin removal by polymyxin-B immobilized derivative fibers during in vitro hemoperfusion of 10% human plasma. ASAIO J 44:54-61, 1998
21. SATO T, ORLOWSKI JP, ZBOROWSKI M. Experimental study of extracorporeal perfusion for septic shock. ASAIO J 39:M790-M793, 1993
22. GOTLOIB L, BARZILAY E, SHUSTAK A, WAIS Z, JAICHENKO J, LEV A. Hemofiltration in septic ARDS. The artificial kidney as an artificial endocrine lung. Resuscitation 13:123-132, 1986
23. BELLOMO R. Continuous hemofiltration as blood purification in sepsis. New Horiz 3:732-737, 1995
24. ELLIOTT D, WILES C III, REYNOLDS HN. Removal of cytokines in septic patients using continuous venovenous hemodiafiltration. (letter) Crit Care Med 22:718-719, 1994
25. MILLAR AB, ARMSTRONG L, VAN DER LINDEN J, MOAT N, EKROTH R, WESTWICK J, SCALLAN M, LINCOLN C. Cytokine production and hemofiltration in children undergoing cardiopulmonary bypass. Ann Thorac Surg 56:1499-1502, 1993
26. ANDREASSON S, GSTHBERG S, BERGGREN H, BENGTSSON A, ERIKSSON E, RISBERG B. Hemofiltration modifies complement activation after extracorporeal circulation in infants. Ann Thorac Surg 56:15151517, 1993
27. BELLOMO R, TIPPING P, BOYCE N. InterIeukin-6 and interIeukin-8 extraction during continuous venovenous hemodiafiltration in septic acute renal failure. Ren Fail 17:457-466, 1995
28. VAN BOMMEL EFH, HESSE CI, JUTTE NH, ZIETSE R, BRUINING HA, WEIMAR W. Cytokine kinetics (TNF-α, IL-lβ, IL-6) during continuous hemofiltration. A laboratory and clinical study. Contrib Nephrol 116:62-75, 1995
29. HOFFMANN J, HARTL W, DEPPISCH R, FAIST E, JOCHUM M, INTIIORN D. Hemofiltration in human sepsis. Evidence for elimination of immunomodulary substances. Kidney Int 48:1563-1570, 1995
30. HOFFMANN J, HARTL W, DEPPISCH R, FAIST E, JOCHUM M, INTHORN D. Effect of hemofiltration on hemodynamics and systemic concentrations of anaphylatoxins and cytokines in human sepsis. Intensive Care Med 22:1360-1367, 1996
31. TONNESEN E, HANSEN M, HOHNDORF K, DIAMANT M, BENUTZEN K, WANSCHER M, TOFT P. Cytokines in plasma and ultrafiltrate during continuous arteriovenous hemofiltration. Anaesth Intensive Care 21:752-758, 1993
32. SANDER A, ARMBRUSTER W, SANDER B, PHILIPP T, SCHAFER C, THURAUF N, LANGE R. The influence of continuous hemofiltration on cytokine elimination and cardiovascular stability in the early phase of sepsis. Contrib Nephrol 116:99-103, 1995
33. GASCHE Y, PASCUAL M, SUTER PM, FAVRE H, CHEVROLET JC, SCHIFFERLI JA. Complement depletion during haemofiltration with polyacrilonitrile membranes. Nephrol Dial Transplant 11:117-119,1996
34. KELL'UM JA, JOHNSON JP, KRAMER D, PALEVSKY P, BRADY JJ, PINSKY MR. Diffusive vs convective therapy. Effects on mediators of inflammation in patients with severe systemic inflammatory response syndrome. Crit Care Med 26:1995-2000, 1998
35. CORAIM FJ, CORAIM HP, EBERMANN R, STELLWAG FM. Acute respiratory failure after cardiac surgery. Clinical experience with the application of continuous arteriovenous hemofiltration. Crit Care Med 14:714-718, 1986
36. BARZILAY E, KESSLER D, BERLOT G, GULLO A, GEBER D, BEN ZEEV I. Use of extracorporeal supportive techniques as additional treatment for septic-induced multiple organ failure patients. Crit Care Med 17:634-637, 1989
37. BAGSIIAW ONT, ANAES FRC, HUTCHINSON A. Continuous arteriovenous hemofiltration and respiratory function in multiple organ systems failure. Intensive Care Med 18:334-338, 1992
38. Di CARLO JV, DUDLEY TE, SHERBOTIE JR, KAPLAN BS, COSTARINO AT. Continuous arteriovenous hemofiltration/dialysis improves pulmonary gas exchange in children with multiple organ system failure. Crit Care Med 18:822-526, 1990
39. BOULAIN T, DELPECH M, LEGRAS A, LANOTTE R, DEQUIN P-F, PERROTIN D. Continuous venovenous hemodiafiltration in acute renal failure associated with multiple organ failure. Influence on outcome. Clin Int Care 7:4-10, 1996
40. RIEGEL W, ZIEGENFUSS TH, BAUER M, MARZI I. Influence of venovenous hemofiltration on posttraumatic inflammation and hemodynamics. Contrib Nephrol 116:56-61, 1995
41. BRAUN N, ROSENFELD S, GIOLAI M, BANZHAF W, FRETSCHNER R, WARTH H, WEINSTOCK C, DEPPISCH R, ERLEY CM, MULLER GA. Effects of continuous hemodiafiltration on IL-6, TNF-alpha, C3a and TCC in patients with SIRS/septic shock using two different membranes. Contrib Nephrol 116:89-98, 1995
42. BELLOMO R, FARMER M, WRIGHT CH, PARKIN G, BOYCE N. Treat-ment of sepsis-associated acute renal failure with continuous hemodiafiltration. Clinical experience and comparison with conventional dialysis. Blood Purif 13:246-254, 1995
43. VAN BOMMEL E, BOUVY N, So KL, VINCENT HH, ZIETSE R, BRUINING HA, WEIMAR W. High-risk surgical acute renal failure treated by continuous arteriovenous hemodiafiltration. Metabolic control and outcome in sixty patients. Nephron 70:185-192,1995
44. GOTLOIB L, SHOSTAK A, LEV A, FUDIN R, JAICHENKO J. Treatment of surgical and non-surgical septic multiorgan failure with bicarbonate hemodialysis and sequential hemofiltration. Intensive Care Med 21:104-111, 1995
45. BELLOMO R, BALWIN I, COLE RONCO C. Preliminary experience with high-volume hemofiltration in human septic shock. Kidney Int 54(Suppl 66):S182-S185, 1998
46. DINARELLO CA. Cytokines, agents provocateurs in hemodialysis? Kidney Int 41:683-694, 1992